ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China …
( read original story …)
Home NEWS ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China
ADVERTISEMENT
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- China’s market regulator launches 5 measures to help rescue Hong Kong’s battered stock market 20/04/2024
- China’s middle-class sees decrease in confidence as economy faces slowdown 20/04/2024
- China Promises American Zoo New Pandas 20/04/2024
- China’s Hillhouse moves to rebuild stake in LONGi following probe on selling 20/04/2024
- China Mobile, Qualcomm, ZTE achieve 5.4 Gbps with 3CC CA test 20/04/2024
- Zambia’s Finance Minister Says the Era of Too Much Debt From China Is Over 20/04/2024
- China’s Securities Regulator Eases Trading Rules With Hong Kong 20/04/2024
- Is that China’s economy [finally] on its way back to the top? 20/04/2024
- Beijing Half Marathon champion has medal taken away after other runners slowed down to let him win 20/04/2024
- China Responds After Israel Strikes Iran 20/04/2024
- China Eyes Foreign Investments for Tech Ambitions Despite Tepid Global Appetite — Update 20/04/2024
- China may be shaking out of its slump, and its economy could grow 5% this year after a surprising first-quarter performance, BofA says 20/04/2024